Rating History for Viridian Therapeutic (VRDN) by Wells Fargo

More Stocks Rated by Wells Fargo | Latest Ratings for VRDN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/29/2026 Derek Archila Upgrade Overweight
(Equal Weight)		 31.00
(N/A)		 17.90
(18.03)		 0.73% Details